初次小梁切除与青光眼引流管植入研究5年随访的治疗结局
多中心随机临床试验纳入242眼药物未控制且无眼部切口手术史的青光眼患者,随机接受350-mm2 Baerveldt引流管或小梁切除联合丝裂霉素C(0.4 mg/ml 2分钟)。5年累积失败率引流管组42% vs 小梁切除组35%(P=0.21;HR=1.31;95%CI 0.86-2.01),眼压两组相似,小梁切除组所需青光眼药物更少。
要点
- 5年累积手术失败率引流管组42% vs 小梁切除组35%(P=0.21;HR=1.31;95%CI 0.86-2.01),无显著差异。
- 5年眼压引流管组13.4±3.5 mmHg vs 小梁切除组13.0±5.2 mmHg(P=0.52),无显著差异。
- 5年青光眼药物数量引流管组2.2±1.3 vs 小梁切除组1.3±1.4(P<0.001),小梁切除组更少。
核心结论
- 小梁切除联合丝裂霉素C与引流管植入术后5年眼压相似,但小梁切除术后所需青光眼药物更少。
- 两种手术方式5年手术失败率无显著差异。
研究设计与样本
- 多中心随机临床试验,纳入242眼(242例)药物未控制且无眼部切口手术史的青光眼患者。
- 引流管组125例,小梁切除组117例,在16个临床中心入组。
- 随机接受350-mm2 Baerveldt青光眼引流管或小梁切除联合丝裂霉素C(0.4 mg/ml 2分钟)。
主要发现
- 5年累积失败概率引流管组42% vs 小梁切除组35%(P=0.21;HR=1.31;95%CI 0.86-2.01)。
- 5年眼压引流管组13.4±3.5 mmHg vs 小梁切除组13.0±5.2 mmHg(P=0.52)。
- 5年青光眼药物数量引流管组2.2±1.3 vs 小梁切除组1.3±1.4(P<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To report 5-year treatment outcomes in the Primary Tube Versus Trabeculectomy (PTVT) Study. DESIGN: Multicenter randomized clinical trial. PARTICIPANTS: A total of 242 eyes of 242 patients with medically uncontrolled glaucoma and no previous incisional ocular surgery, including 125 patients in the tube group and 117 patients in the trabeculectomy group. METHODS: Patients were enrolled at 16 clinical centers and randomly assigned to treatment with a tube shunt (350-mm2 Baerveldt glaucoma implant) or trabeculectomy with mitomycin C (MMC) (0.4 mg/ml for 2 minutes). MAIN OUTCOME MEASURES: The primary outcome measure was the rate of surgical failure, defined as intraocular pressure (IOP) > 21 mmHg or reduced < 20% from baseline, IOP ≤ 5 mmHg, reoperation for glaucoma, or loss of light perception. Secondary outcome measures included IOP, glaucoma medical therapy, and visual acuity. RESULTS: The cumulative probability of failure after 5 years of follow-up was 42% in the tube group and 35% in the trabeculectomy group (P = 0.21; hazard ratio = 1.31; 95% confidence interval = 0.86-2.01). At 5 years, IOP (mean ± standard deviation) was 13.4 ± 3.5 mmHg in the tube group and 13.0 ± 5.2 mmHg in the trabeculectomy group (P = 0.52), and the number of glaucoma medications (mean ± standard deviation) was 2.2 ± 1.3 in the tube group and 1.3 ± 1.4 in the trabeculectomy group (P < 0.001). CONCLUSIONS: Trabeculectomy with MMC and tube shunt surgery produced similar IOPs after 5 years of follow-up in the PTVT Study, but fewer glaucoma medications were required after trabeculectomy. No significant difference in the rate of surgical failure was observed between the 2 surgical procedures at 5 years.
引用
- Gedde SJ, Feuer WJ, Lim KS, et al. Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 5 Years of Follow-up. Ophthalmology. 2022. PMID: 35835337. doi:10.1016/j.ophtha.2022.07.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。